Cancer Genetics (CGIX) Enters $20M Controlled Equity Offering
Tweet Send to a Friend
Cancer Genetics (NASDAQ: CGIX) disclosed the following on Thursday:Item 1.01. Entry into a Material Definitive Agreement. On July 15 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
